24 October 2024 Biologics Bullous Pemphigoid ‘Breakthrough’ mAb in moderate to severe bullous pemphigoid
1 June 2023 Biologics Medications Osteoporosis Pharmaceuticals Women Denosumab beats alendronate on fracture risk